GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.00, with a volume of 386,182 shares trading hands.
GB Sciences Stock Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Featured Articles
- Five stocks we like better than GB Sciences
- What is the Nikkei 225 index?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is the Hang Seng index?
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
